Skip to main content
Top
Published in: International Journal of Hematology 4/2011

01-10-2011 | Original Article

An evaluation of peripherally inserted central venous catheters for children with cancer requiring long-term venous access

Authors: Naoki Hatakeyama, Tsukasa Hori, Masaki Yamamoto, Nobuo Mizue, Natsuko Inazawa, Keita Igarashi, Hiroyuki Tsutsumi, Nobuhiro Suzuki

Published in: International Journal of Hematology | Issue 4/2011

Login to get access

Abstract

Long-term venous access is essential when treating malignant diseases. We reviewed our experience with peripherally inserted central venous catheters (PICC) in children suffering from various malignancies with regard to catheter life, reasons for removal, and complications. Ninety-three PICCs were inserted in 78 children. Median catheter life was 162 days (range 6–575 days) with a total of 16,266 catheter days. Seventy-five PICCs (80.6%) had been placed until the elective removal or patients’ death, whereas 18 PICCs (19.4%) were removed due to PICC-related complications; a rate of 1.11 per 1,000 catheter days. Complications requiring removal of PICCs included infection (n = 12), occlusion (n = 3), dislodgement (n = 2), and phlebitis (n = 1) with rates of 0.74, 0.18, 0.12 and 0.06 per 1,000 catheter days, respectively. We conclude that PICC provides reliable long-term intravenous access in children suffering from malignancies.
Literature
3.
go back to reference Ryder MA. Peripheral access options. Surg Oncol Clin N Am. 1995;4:395–427.PubMed Ryder MA. Peripheral access options. Surg Oncol Clin N Am. 1995;4:395–427.PubMed
4.
go back to reference Cardella JF, Cardella K, Bacci N, Fox PS, Post JH. Cumulative experience with 1, 273 peripherally inserted central catheters at a single institution. J Vasc Interv Radiol. 1996;7:5–13.CrossRefPubMed Cardella JF, Cardella K, Bacci N, Fox PS, Post JH. Cumulative experience with 1, 273 peripherally inserted central catheters at a single institution. J Vasc Interv Radiol. 1996;7:5–13.CrossRefPubMed
5.
go back to reference Walshe LJ, Malak SF, Eagan J, Sepkowitz KA. Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol. 2002;20:3276–81.CrossRefPubMed Walshe LJ, Malak SF, Eagan J, Sepkowitz KA. Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol. 2002;20:3276–81.CrossRefPubMed
6.
go back to reference Yap YS, Karapetis C, Lerose S, Iyer S, Koczwara B. Reducing the risk of peripherally inserted central catheter line complications in the oncology setting. Eur J Cancer Care. 2006;15:342–7.CrossRef Yap YS, Karapetis C, Lerose S, Iyer S, Koczwara B. Reducing the risk of peripherally inserted central catheter line complications in the oncology setting. Eur J Cancer Care. 2006;15:342–7.CrossRef
7.
go back to reference Matsuzaki A, Suminoe A, Koga Y, Hatano M, Hattori S, Hara T. Long-term use of peripherally inserted central venous catheters for cancer chemotherapy in children. Support Care Cancer. 2006;14:153–60.CrossRefPubMed Matsuzaki A, Suminoe A, Koga Y, Hatano M, Hattori S, Hara T. Long-term use of peripherally inserted central venous catheters for cancer chemotherapy in children. Support Care Cancer. 2006;14:153–60.CrossRefPubMed
8.
go back to reference Shen G, Gao Y, Wang Y, Mao B, Wang X. Survey of the long-term use of peripherally inserted central venous catheters in children with cancer: experience in a developing country. J Pediatr Hematol Oncol. 2009;31:489–92.CrossRefPubMed Shen G, Gao Y, Wang Y, Mao B, Wang X. Survey of the long-term use of peripherally inserted central venous catheters in children with cancer: experience in a developing country. J Pediatr Hematol Oncol. 2009;31:489–92.CrossRefPubMed
9.
go back to reference Abedin S, Kapoor G. Peripherally inserted central venous catheters are a good option for prolonged venous access in children with cancer. Pediatr Blood Cancer. 2008;51:251–5.CrossRefPubMed Abedin S, Kapoor G. Peripherally inserted central venous catheters are a good option for prolonged venous access in children with cancer. Pediatr Blood Cancer. 2008;51:251–5.CrossRefPubMed
10.
go back to reference Donowitz GR, Maki DG, Crnich CJ, Pappas PG, Rolston KV. Infections in the neutropenic patient—new views of an old problem. Hematology Am Soc Hematol Educ Program 2001; 113–39. Donowitz GR, Maki DG, Crnich CJ, Pappas PG, Rolston KV. Infections in the neutropenic patient—new views of an old problem. Hematology Am Soc Hematol Educ Program 2001; 113–39.
11.
go back to reference Bethune K, Allwood M, Grainger C, Wormleighton C. Use of filters during the preparation and administration of parenteral nutrition: position paper and guidelines prepared by a British pharmaceutical nutrition group working party. Nutrition. 2001;17:403–8.CrossRefPubMed Bethune K, Allwood M, Grainger C, Wormleighton C. Use of filters during the preparation and administration of parenteral nutrition: position paper and guidelines prepared by a British pharmaceutical nutrition group working party. Nutrition. 2001;17:403–8.CrossRefPubMed
12.
go back to reference Ball PA. Intravenous in-line filters: filtering the evidence. Curr Opin Clin Nutr Metab Care. 2003;6:319–25.PubMed Ball PA. Intravenous in-line filters: filtering the evidence. Curr Opin Clin Nutr Metab Care. 2003;6:319–25.PubMed
13.
go back to reference O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol. 2002;23:759–69.CrossRefPubMed O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol. 2002;23:759–69.CrossRefPubMed
14.
go back to reference Friedland G. Infusion-related phlebitis—is the in-line filter the solution? N Engl J Med. 1985;312:113–5.CrossRefPubMed Friedland G. Infusion-related phlebitis—is the in-line filter the solution? N Engl J Med. 1985;312:113–5.CrossRefPubMed
15.
go back to reference Fratino G, Molinari AC, Parodi S, Longo S, Saracco P, Castagnola E, et al. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol. 2005;16:648–54.CrossRefPubMed Fratino G, Molinari AC, Parodi S, Longo S, Saracco P, Castagnola E, et al. Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol. 2005;16:648–54.CrossRefPubMed
16.
go back to reference Cesaro S, Tridello G, Cavaliere M, Magagna L, Gavin P, Cusinato R, et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. J Clin Oncol. 2009;27:2059–65.CrossRefPubMed Cesaro S, Tridello G, Cavaliere M, Magagna L, Gavin P, Cusinato R, et al. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer. J Clin Oncol. 2009;27:2059–65.CrossRefPubMed
Metadata
Title
An evaluation of peripherally inserted central venous catheters for children with cancer requiring long-term venous access
Authors
Naoki Hatakeyama
Tsukasa Hori
Masaki Yamamoto
Nobuo Mizue
Natsuko Inazawa
Keita Igarashi
Hiroyuki Tsutsumi
Nobuhiro Suzuki
Publication date
01-10-2011
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2011
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-011-0928-2

Other articles of this Issue 4/2011

International Journal of Hematology 4/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine